Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy.

While the bulk of thyroid cancer sufferers are simply treatable, these with anaplastic or poorly differentiated recurrent thyroid carcinomas have…

Continue Reading →